CONTINUE TO SITE

OR WAIT null SECS

2021 ASCO Updates in HER2-Positive Breast Cancer Biochemical Recurrence in Prostate Cancer Emerging and Existing Treatment Regimens for Transplant-Ineligible DLBCL NCCN Guidelines Update for HR+ Breast Cancer Updates in the Management of Extensive-Stage Small Cell Lung Cancer

2021 ASCO Updates in HER2-Positive Breast CancerBiochemical Recurrence in Prostate Cancer Emerging and Existing Treatment Regimens for Transplant-Ineligible DLBCLNCCN Guidelines Update for HR+ Breast CancerUpdates in the Management of Extensive-Stage Small Cell Lung Cancer

Clinical

View More Brain Cancer Breast Cancer Colorectal Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecologic Cancer Hematology Leukemia Lung Cancer Lymphoma Pediatric Cancers Skin Cancer

Brain CancerBreast CancerColorectal CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer

News

All News NP/PA Practice Management Technology

All NewsNP/PAPractice ManagementTechnology

Media

Around the Practice Between the Lines Clinical Consult Enduring Webinars Expert Interviews Medical World News OncView Podcasts Readout 360 Tumor Board Series

Around the PracticeBetween the LinesClinical ConsultEnduring WebinarsExpert InterviewsMedical World NewsOncViewPodcastsReadout 360Tumor Board Series

Conferences

Publications

About Oncology Journal MBCC Abstract Supplement Oncology Journal

About Oncology JournalMBCC Abstract SupplementOncology Journal

Events

Live Events Virtual Events

Live EventsVirtual Events

CME/CE

Resources

Image IQ Partners Polls Quizzes Slideshows Sponsored Toolkits Tumor Board

Image IQPartnersPollsQuizzesSlideshowsSponsoredToolkitsTumor Board

eNewsletter Print Subscription

eNewsletterPrint Subscription

CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Spotlight

2021 ASCO Updates in HER2-Positive Breast Cancer
Biochemical Recurrence in Prostate Cancer
Emerging and Existing Treatment Regimens for Transplant-Ineligible DLBCL
NCCN Guidelines Update for HR+ Breast Cancer
Updates in the Management of Extensive-Stage Small Cell Lung Cancer

ClinicalSee All >

Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer

CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Zoneddy Dayao, MD | Authors

1481 PLUMAS ST

Articles

HER2-Targeted Therapy for Early-Stage Breast Cancer: A Comprehensive Review

April 15, 2014

This review discusses the treatment of primary, nonmetastatic HER2-positive breast cancer in the adjuvant and neoadjuvant settings-settings in which tremendous progress has been made.